SV2007002309A - Compuestos 5-nitro-nucleosidos para tratar infecciones virales - Google Patents
Compuestos 5-nitro-nucleosidos para tratar infecciones viralesInfo
- Publication number
- SV2007002309A SV2007002309A SV2005002309A SV2005002309A SV2007002309A SV 2007002309 A SV2007002309 A SV 2007002309A SV 2005002309 A SV2005002309 A SV 2005002309A SV 2005002309 A SV2005002309 A SV 2005002309A SV 2007002309 A SV2007002309 A SV 2007002309A
- Authority
- SV
- El Salvador
- Prior art keywords
- compounds
- viral infections
- nucleosid
- nitro
- treat viral
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/14—Pyrrolo-pyrimidine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/22—Pteridine radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
COMPUESTOS, COMPOSICIONES Y METODOS PARA TRATAR INFECCIONES VIRALES CAUSADAS POR UN VIRUS DE LA FAMILIA FLAVIVIRIDAE, COMO EJEMPLO VIRUS DE HEPATITIS C
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63045304P | 2004-11-22 | 2004-11-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
SV2007002309A true SV2007002309A (es) | 2007-02-27 |
Family
ID=37012089
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SV2005002309A SV2007002309A (es) | 2004-11-22 | 2005-11-22 | Compuestos 5-nitro-nucleosidos para tratar infecciones virales |
Country Status (6)
Country | Link |
---|---|
US (1) | US7414031B2 (es) |
AR (1) | AR057641A1 (es) |
SV (1) | SV2007002309A (es) |
TW (1) | TW200631585A (es) |
UY (1) | UY29225A1 (es) |
WO (1) | WO2006121468A1 (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY164523A (en) | 2000-05-23 | 2017-12-29 | Univ Degli Studi Cagliari | Methods and compositions for treating hepatitis c virus |
NZ547204A (en) | 2000-05-26 | 2008-01-31 | Idenix Cayman Ltd | Methods and compositions for treating flaviviruses and pestiviruses |
NZ537662A (en) * | 2002-06-28 | 2007-10-26 | Idenix Cayman Ltd | 2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections |
AU2003248748A1 (en) * | 2002-06-28 | 2004-01-19 | Idenix (Cayman) Limited | 2'-c-methyl-3'-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections |
US7608600B2 (en) | 2002-06-28 | 2009-10-27 | Idenix Pharmaceuticals, Inc. | Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections |
KR20050088079A (ko) * | 2002-11-15 | 2005-09-01 | 이데닉스 (케이만) 리미티드 | 2'-분지형 뉴클레오시드 및 플라비비리다에 돌연변이 |
CA2509687C (en) * | 2002-12-12 | 2012-08-14 | Idenix (Cayman) Limited | Process for the production of 2'-branched nucleosides |
TW200720285A (en) * | 2005-04-25 | 2007-06-01 | Genelabs Tech Inc | Nucleoside compounds for treating viral infections |
JP5254033B2 (ja) * | 2005-12-23 | 2013-08-07 | イデニク プハルマセウティカルス,インコーポレイテッド | 分岐型ヌクレオシドを調製するための合成中間体の製造方法 |
WO2010015637A1 (en) * | 2008-08-06 | 2010-02-11 | Novartis Ag | New antiviral modified nucleosides |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4107288A (en) * | 1974-09-18 | 1978-08-15 | Pharmaceutical Society Of Victoria | Injectable compositions, nanoparticles useful therein, and process of manufacturing same |
CA2079105C (en) * | 1990-04-04 | 2000-06-13 | Michael Houghton | Hepatitis c virus protease |
US5145684A (en) * | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
CA2159639A1 (en) * | 1993-04-02 | 1994-10-13 | Vincent J. Miles | Method for selective inactivation of viral replication |
IT1272179B (it) * | 1994-02-23 | 1997-06-16 | Angeletti P Ist Richerche Bio | Metodologia per riprodurre in vitro l'attivita' proteolitica della proteasi ns3 del virus hcv. |
US5861267A (en) * | 1995-05-01 | 1999-01-19 | Vertex Pharmaceuticals Incorporated | Methods, nucleotide sequences and host cells for assaying exogenous and endogenous protease activity |
ATE318896T1 (de) | 1995-09-27 | 2006-03-15 | Univ Emory | Rekombinante rna-replikase von hepatitis-c-virus |
US5759795A (en) * | 1996-03-08 | 1998-06-02 | Schering Corporation | Assay for determining inhibitors of ATPase |
EP0975809A4 (en) * | 1997-03-05 | 2002-10-30 | Univ Washington | EXAMINATION PROCEDURE FOR DETECTING AGENTS FOR SELECTIVE INHIBITION OF HCV REPLICATION |
DE69838513T2 (de) * | 1997-12-11 | 2008-07-03 | Smithkline Beecham Corp. | Verkürztes hepatitis-c-virus protein nsb5 und methoden, um antivirale substanzen zu identifizieren |
MY164523A (en) | 2000-05-23 | 2017-12-29 | Univ Degli Studi Cagliari | Methods and compositions for treating hepatitis c virus |
US20030008841A1 (en) | 2000-08-30 | 2003-01-09 | Rene Devos | Anti-HCV nucleoside derivatives |
US7105499B2 (en) * | 2001-01-22 | 2006-09-12 | Merck & Co., Inc. | Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
MXPA03006514A (es) * | 2001-01-22 | 2004-12-02 | Merck & Co Inc | Derivados de nucleosidos como inhibidores de polimerasa de acido ribonucleico viral dependiente de acido ribonucleico. |
WO2003061385A1 (en) | 2002-01-17 | 2003-07-31 | Ribapharm Inc. | Tricyclic nucleoside library compounds, synthesis, and use as antiviral agents |
WO2003062256A1 (en) | 2002-01-17 | 2003-07-31 | Ribapharm Inc. | 2'-beta-modified-6-substituted adenosine analogs and their use as antiviral agents |
AU2003269902A1 (en) | 2002-07-16 | 2004-02-02 | Isis Pharmaceuticals, Inc. | Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
US7094768B2 (en) * | 2002-09-30 | 2006-08-22 | Genelabs Technologies, Inc. | Nucleoside derivatives for treating hepatitis C virus infection |
WO2004028481A2 (en) | 2002-09-30 | 2004-04-08 | Genelabs Technologies, Inc. | Nucleoside derivatives for treating hepatitis c virus infection |
MXPA06002198A (es) | 2003-08-27 | 2007-08-14 | Biota Scient Management | Nucleosidos o nucleotidos triciclicos novedosos como agentes terapeuticos. |
US7151089B2 (en) * | 2003-10-27 | 2006-12-19 | Genelabs Technologies, Inc. | Nucleoside compounds for treating viral infections |
US7202223B2 (en) * | 2003-10-27 | 2007-04-10 | Genelabs Technologies, Inc. | Nucleoside compounds for treating viral infections |
MXPA06004680A (es) | 2003-10-27 | 2007-04-17 | Genelabs Tech Inc | Compuestos de nucleosido para el tratamiento de infecciones virales. |
-
2005
- 2005-11-15 US US11/280,984 patent/US7414031B2/en not_active Expired - Fee Related
- 2005-11-15 WO PCT/US2005/041389 patent/WO2006121468A1/en active Application Filing
- 2005-11-21 TW TW094140873A patent/TW200631585A/zh unknown
- 2005-11-21 AR ARP050104878A patent/AR057641A1/es not_active Application Discontinuation
- 2005-11-22 SV SV2005002309A patent/SV2007002309A/es not_active Application Discontinuation
- 2005-11-24 UY UY29225A patent/UY29225A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
US20060111311A1 (en) | 2006-05-25 |
UY29225A1 (es) | 2006-06-30 |
AR057641A1 (es) | 2007-12-12 |
WO2006121468A1 (en) | 2006-11-16 |
TW200631585A (en) | 2006-09-16 |
US7414031B2 (en) | 2008-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY28581A1 (es) | Compuestos nucleosidicos para el tratamiento de infecciones virales | |
SV2007002309A (es) | Compuestos 5-nitro-nucleosidos para tratar infecciones virales | |
TW200720285A (en) | Nucleoside compounds for treating viral infections | |
CY1111423T1 (el) | Αναστολεις ns5b hcv | |
CO6430431A2 (es) | Inhibidores del virus de la hepatitis c | |
CR10776A (es) | Inhibidores de la proteasa ns3 del hcv | |
TW200602064A (en) | Nucleoside derivatives for treating hepatitis C virus infection | |
DOP2006000171A (es) | Inhibidores de proteasa ns3 del vhc | |
ATE469155T1 (de) | Cyclopropyl-fusionierte indolbenzazepin-hcv-ns5b- hemmer | |
EA201000201A1 (ru) | Азотсодержащие бициклические химические вещества для лечения вирусных инфекций | |
ECSP13010937A (es) | Compuestos antivirales | |
ECSP11011310A (es) | Análogos carba - nucleósido para tratamiento antiviral | |
ECSP088518A (es) | Nucleósidos antivirales | |
CO6361922A2 (es) | Inhibidores del virus de la hepatitis c | |
EA200701850A1 (ru) | Соединения трициклических нуклеозидов (варианты), фармацевтическая композиция на их основе и способ лечения или профилактики вирусных инфекций у млекопитающих | |
CR9731A (es) | Inhibidores de proteasa ns3 del vhc | |
CL2009000305A1 (es) | Compuestos derivados de 2-aril-sustituido-1-benzofurano-3-carboxamida, inhibidores de la polimerasa ns5b; composicion farmaceutica; y su uso en el tratamiento de una enfermedad causada por el virus de la hepatitis c (hcv). | |
CO6190510A2 (es) | Inhibidores del virus de la hepatitis c | |
EA201270423A1 (ru) | Ингибиторы протеазы hcv | |
DK2209789T3 (da) | Cyclopropyl-kondenserede indolobenzazepin HCV NS5B-hæmmere | |
ATE522532T1 (de) | Verbindungen zur behandlung von hepatitis c | |
EA201000948A1 (ru) | Ингибиторы вирусной полимеразы | |
ATE494291T1 (de) | Verbindungen zur behandlung von hepatitis c | |
ATE551343T1 (de) | Tetracyclische verbindungen zur behandlung von hepatitis c | |
EA201000277A1 (ru) | Соединения для лечения гепатита с |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Lapse |